Anti-Obesity Drugs Market Report by Drug Class (Peripherally Acting Drugs, Centrally Acting Drugs), Drug Type (Prescription Drugs, OTC Drugs), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2024-2032

Anti-Obesity Drugs Market Report by Drug Class (Peripherally Acting Drugs, Centrally Acting Drugs), Drug Type (Prescription Drugs, OTC Drugs), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A5544
Buy Now

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Anti-Obesity Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Drug Class
    6.1    Peripherally Acting Drugs
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Centrally Acting Drugs
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Drug Type
    7.1    Prescription Drugs
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    OTC Drugs
        7.2.1 Market Trends
        7.2.2 Market Forecast
8   Market Breakup by Distribution Channel
    8.1    Hospital Pharmacy
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Retail Pharmacy
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Online Pharmacy
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Boehringer Ingelheim International GmbH
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
        14.3.2    Currax Pharmaceuticals LLC
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Gelesis
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    GlaxoSmithKline plc
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Merck & Co. Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Norgine B.V.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
        14.3.7    Novo Nordisk A/S 
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Pfizer Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
        14.3.9    Rhythm Pharmaceuticals Inc.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
        14.3.10    SHIONOGI & Co. Ltd.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Takeda Pharmaceutical Company Limited
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis
        14.3.12    Vivus LLC
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio

List of Figures

Figure 1: Global: Anti-Obesity Drugs Market: Major Drivers and Challenges
Figure 2: Global: Anti-Obesity Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Anti-Obesity Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Anti-Obesity Drugs Market: Breakup by Drug Class (in %), 2023
Figure 5: Global: Anti-Obesity Drugs Market: Breakup by Drug Type (in %), 2023
Figure 6: Global: Anti-Obesity Drugs Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Anti-Obesity Drugs Market: Breakup by Region (in %), 2023
Figure 8: Global: Anti-Obesity Drugs (Peripherally Acting Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Anti-Obesity Drugs (Peripherally Acting Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Anti-Obesity Drugs (Centrally Acting Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Anti-Obesity Drugs (Centrally Acting Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Anti-Obesity Drugs (Prescription Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Anti-Obesity Drugs (Prescription Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Anti-Obesity Drugs (OTC Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Anti-Obesity Drugs (OTC Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Anti-Obesity Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Anti-Obesity Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Anti-Obesity Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Anti-Obesity Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Anti-Obesity Drugs (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Anti-Obesity Drugs (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: North America: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: North America: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: United States: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: United States: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Canada: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Canada: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Asia-Pacific: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Asia-Pacific: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: China: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: China: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Japan: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Japan: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: India: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: India: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: South Korea: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: South Korea: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Australia: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Australia: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Indonesia: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Indonesia: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Others: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Others: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Europe: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Europe: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Germany: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Germany: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: France: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: France: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: United Kingdom: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: United Kingdom: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Italy: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Italy: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Spain: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Spain: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Russia: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Russia: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Others: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Others: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Latin America: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Latin America: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Brazil: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Brazil: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Mexico: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Mexico: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Others: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Others: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Middle East and Africa: Anti-Obesity Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Middle East and Africa: Anti-Obesity Drugs Market: Breakup by Country (in %), 2023
Figure 70: Middle East and Africa: Anti-Obesity Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Global: Anti-Obesity Drugs Industry: SWOT Analysis
Figure 72: Global: Anti-Obesity Drugs Industry: Value Chain Analysis
Figure 73: Global: Anti-Obesity Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Anti-Obesity Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Anti-Obesity Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 3: Global: Anti-Obesity Drugs Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
Table 4: Global: Anti-Obesity Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Anti-Obesity Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Anti-Obesity Drugs Market: Competitive Structure
Table 7: Global: Anti-Obesity Drugs Market: Key Players

Anti-Obesity Drugs Market Report by Drug Class (Peripherally Acting Drugs, Centrally Acting Drugs), Drug Type (Prescription Drugs, OTC Drugs), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More